Firm Gets Patent on Protein Group

International Genetic Engineering Inc. said it has been issued a U.S. patent on a class of proteins named regressens--antigens associated with tumor regression.

The company said the proteins may complement other types of biological therapy, and may be used in addition to conventional approaches to cancer treatment.

It noted that considerable development work remains to determine the safety and clinical efficacy of the patented immunogens.